Deficiency of intracellular glutathione can worsen oxidative stress and accelerate cellular death in diseases such as Alzheimer disease, Parkinson disease, liver disease, cystic fibrosis, sickle cell anemia, HIV/AIDS and diabetes
Eli Lilly dominated the pharma landscape in 2025 powered by the exponential growth of the GLP-1 receptor agonist (RA) market to become the largest company in the industry by market cap, with the road ahead expected to be even more lucrative
Research of the impact of buffer capacity, pH and temperature on the stability of semaglutide have meticulously described how excursions at different temperatures produce increases in the degradation products and reductions in the amount of intact and active peptide in solution
Understanding the GLP-1 Safety Profile Most short-term studies indicate that GLP-1 medications are generally well-tolerated
Genet Genom
About 56% of participants had type 2 diabetes, and about 73% had obesity